Mark Canney
@markcanney
Nephrologist @OttawaHospital @OttawaRenal | Assistant Professor @uOttawaMed
ID: 1228520147129782275
15-02-2020 03:23:51
109 Tweet
326 Followers
178 Following
Fantastic work by ⭐️ medical student Erin Deacon uOttawa | Faculté de médecine, Faculty of Medicine
Together with Julia Murphy @akonvalinka1 and @sarah_crome, I'm so excited and proud to share our article, hot off the press in Nature Communications where we use scRNAseq to profile the transcriptional landscape of healthy human kidney 👇1/ nature.com/articles/s4146…
The ISN Executive Committee and Council have approved four “ISN-Named Fellows.” Please join us in congratulating: 🥇 Carinna Hockham 🥇 Anastasiia Zykova 🥇 Mark Canney 🥇 Suman Behera theisn.org/blog/2022/12/0… #ThisIsISN - Advancing kidney health worldwide. Together.
Very interesting study and great explanation of the findings by David Collister
The Association Between the Urine Protein-to-Albumin Gap and the Diagnosis of Multiple Myeloma buff.ly/3Gja414 Ottawa Renal Manish M Sood MD Ayub Akbari Alissa Visram @arleighmccurdy Greg Knoll Mark Canney Peter Tanuseputro Manish M Sood MD Ayub Akbari
I am looking for my 1st PhD student University of Alberta to help lead CIHR funded work in eGFR equations in gender diverse adults. Come join a vibrant and diverse team and learn about patient oriented research, biostatistics and biomarkers. Canadian Nephrology Trials Network Can-SOLVE CKD Network - Le réseau Can-SOLVE CKD gradpositions.med.ualberta.ca
This study found that withholding tacrolimus before initiation of nirmatrelvir/ritonavir with resumption 3 days after completion of therapy resulted in a low incidence of supratherapeutic levels bit.ly/CJASN0186 Greg Knoll Swapnil Hiremath @hswapnil.medsky.social Ottawa Renal The Ottawa Hospital
Biomarkers in acute kidney injury: On the cusp of a new era? buff.ly/3NDlPDq In this Commentary, Mark Canney, Edward G. Clark & Swapnil Hiremath @hswapnil.medsky.social @UOttawa provide a diagnostic framework for incorporating CXCL9 testing in the evaluation of AKI. Related: buff.ly/3D2ZUkh
Nirmatrelvir/ritonavir reduces the risk of COVID-19–related complications in patients at high risk for severe COVID-19. This Podcast describes the clinical experience with nirmatrelvir/ritonavir at Ottawa Renal transplant program bit.ly/CPOD0186 Greg Knoll Swapnil Hiremath @hswapnil.medsky.social
Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study bit.ly/3ZCDnW1 Mark Canney Heather Gunning Sean Barbour Ottawa Renal UBC Nephrology
The The ALTER AKI Trial is now live! The Ottawa Hospital's (amazing) ICU research coordinators have enrolled 12 participants since late Nov! Looking forward to upcoming SIVs at KingstonHSC NiagaraHealth & UOHI-ICUO. @JeannieCallum Ron Wald Sean Bagshaw CCCTG Canadian Nephrology Trials Network #CTTG
🎧Dive into the world of contrast-induced #nephropathy with Swapnil Hiremath @hswapnil.medsky.social in the FIRST episode of the new ERA podcast series #APinchOfSalt 🔗 3 episodes are now available on Spotify, YouTube, Amazon Music, and more! 🔊 Hit play now 👉 bit.ly/3SdsxU0
This is very cool! Some great clinical pearls in here too Ottawa Renal Pierre Antoine Brown